Argentina vs Mauritania: HIV-positive TB patients on ART (antiretroviral therapy)
Argentina
69.0%
in 2024
Mauritania
69.0%
in 2023
Argentina rank
128th
Mauritania rank
128th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Argentina
- Mauritania
How they compare
Argentina currently reports 69.0% against 69.0% in Mauritania, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2008 it was Mauritania ahead.
Argentina ranks 128th and Mauritania ranks 128th of 144 countries.
Mauritania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 84.0% | 100.0% | 16.0% | Mauritania |
| 2010s | 4.7% | 93.0% | 88.3% | Mauritania |
| 2020s | 78.0% | 81.0% | 3.0% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Argentina or Mauritania?
- Argentina, at 69.0% against 69.0% in Mauritania as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Argentina and Mauritania?
- 0.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Mauritania?
- 6 years are reported by both, from 2008 to 2023.
- How do Argentina and Mauritania rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Argentina ranks 128th and Mauritania ranks 128th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.